Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
基本信息
- 批准号:10428867
- 负责人:
- 金额:$ 2.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-16 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAcetylationAdoptive TransferAffectAntigensAntiviral AgentsBindingBlocking AntibodiesCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell Differentiation processCellsChIP-seqChromatinChronicComputer AnalysisCytokine SignalingDevelopmentEffector CellEnhancersEpigenetic ProcessFlow CytometryGeneticGenetic TranscriptionGoalsHeterogeneityIndividualInfectionInflammatoryInterferonsInterleukin-10KnowledgeLymphocytic choriomeningitis virusMalignant NeoplasmsMediatingModelingMolecular GeneticsNamesPD-1 blockadePathway interactionsPhenotypePopulationProcessRNA InterferenceRegulator GenesResearchSignal TransductionSiteSolidSurfaceT cell differentiationT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTimeViralVirusVirus Diseasesacute infectionantiviral immunitybasecancer immunotherapychronic infectioncytokinedesigneffector T cellexhaustexhaustionextracellularimprovedinsightprogenitorprogrammed cell death protein 1receptorresponseself-renewalsingle-cell RNA sequencingstem cellssuccesssynergism
项目摘要
ABSTRACT
T cell exhaustion is a differentiation state that is marked by the loss of effector function and increased
expression of inhibitory receptors such as PD-1. Although virus-specific CD8 T cells are commonly considered
as a homogeneous population that gradually become exhausted over time, recent research has clearly
demonstrated that a CXCR5hi TCF-1hi subset is serving as a self-renewing progenitor population that can give
rise to a more terminally exhausted CXCR5lo TCF-1lo subset. To better dissect the heterogeneity of “exhausted”
CD8 T cells, the lab applied single cell RNA-seq (scRNA-seq) to the chronic LCMV infection and identified
three major subsets of virus-specific CD8 T cells that are phenotypically, functionally and transcriptionally
distinct. Not only had the lab validated the existence of these subsets of T cells experimentally by flow
cytometry, more advanced computational analyses were also performed to further predict their core
transcriptional networks and developmental trajectories. Collectively, the findings reveal that a TCF-1hi
progenitor subset can give rise to either a truly exhausted PD-1hi subset or a newly identified functional effector
population that is named CX3CR1hi subset. This discovery laid a solid framework that allows testing of how
extracellular signals and intrinsic genetic circuits regulate the formation and function of these three subsets of
CD8 T cells. More importantly, it provides unprecedented opportunities to explore the possibility of generating
more functional CX3CR1hi cells from TCF-1hi progenitors to overcome T cell exhaustion. This conceptual
breakthrough is obviously applicable to control over chronic viral infection as well as cancer. Intriguingly, the
preliminary study has also demonstrated that CD4 helper T cells, possibly through producing IL-21, are critical
for TCF-1hi CX3CR1hi transition. This led to the hypothesis that inflammatory cytokines (such as CD4-
derived IL-21) modulate the cellular, functional and transcriptional diversity of virus-specific CD8 T cells during
chronic LCMV infection. Blocking antibodies, RNA interference and genetic deletion models will be used to
further dissect how inflammatory cytokines and transcriptional networks regulate heterogeneity in T cell
exhaustion. Furthermore, the lab proposes to redirect CD8 T cell differentiation away from “exhaustion” by
providing additional “CD4 help”, either alone or in combination with PD-1 blockade. The lab will test if providing
IL-21 producing CD4 T cells through adoptive transfer could drive TCF-1hi progenitor cell differentiation into
functional CX3CR1hi effector cells. Overall, knowledge gained from this research will provide mechanistic
insights into how to redirect the formation of functional effector T cells and simultaneously limit T cell
exhaustion for improved viral control over chronic infection.
抽象的
T细胞耗尽是一种区分状态,其标志着效应函数的丧失和增加
通常认为抑制性受体(例如PD-1)。
就像随着时间的流逝逐渐疲惫的同质人群一样,最近的研究显然已经
证明CXCR5HI TCF-1HI子集是一个自我更新人群的服务
上升到更耗尽的CXCR5LO TCF-1LO子集。
CD8 T细胞,实验室应用了单细胞RNA-Seq(SCRNA-Seq)慢性LCMV感染并鉴定
病毒特异性CD8 T细胞的三个主要子集,在功能和转录上是表型的
不同的。
还进行了细胞仪,更先进的计算分析以进一步预测其核心
转录网络和发展轨迹。
祖细胞子集可能会引起耗尽的PD-1HI子集或新的iDenticational效应器
名为CX3CR1HI子集的人口。
细胞外信号和内在遗传回路调节地层,并关闭子集
CD8 T细胞。
来自TCF-1HI祖细胞的功能性CX3CR1HI细胞克服T细胞的耗竭
突破显然适用于控制慢性病毒感染和癌症
初步研究还表明,尽管产生IL-21,CD4辅助T细胞可能是至关重要的
对于TCF-1HICX3CR1HI过渡。
在病毒特异性CD8 T细胞中的细胞,功能和转录多样性范围内
慢性LCMV感染。
进一步剖析炎症细胞因子和转录网络如何调节t细胞的异质性
精疲力尽。
单独或与PD-1封锁结合使用其他“ CD4帮助”。
产生CD4的IL-21通过收养转移告诉TCF-1HI祖细胞细胞细胞分化可能
功能性CX3CR1HI效应细胞总体上从研究中获得的知识提供了机械
深入了解如何重定向功能性T细胞的形成和同时限制T细胞
提高对慢性感染的病毒控制的呼气。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEIGUO CUI其他文献
WEIGUO CUI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEIGUO CUI', 18)}}的其他基金
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10743327 - 财政年份:2022
- 资助金额:
$ 2.85万 - 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
- 批准号:
10209655 - 财政年份:2021
- 资助金额:
$ 2.85万 - 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
- 批准号:
10591599 - 财政年份:2021
- 资助金额:
$ 2.85万 - 项目类别:
The cellular mechanisms of immunological memory development in COVID-19 patients
COVID-19患者免疫记忆发展的细胞机制
- 批准号:
10745497 - 财政年份:2021
- 资助金额:
$ 2.85万 - 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
- 批准号:
10372226 - 财政年份:2021
- 资助金额:
$ 2.85万 - 项目类别:
The cellular mechanisms of immunological memory development in COVID-19 patients
COVID-19患者免疫记忆发展的细胞机制
- 批准号:
10465343 - 财政年份:2021
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10721409 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10536743 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10311054 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别:
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
CD8 T 细胞功能适应慢性病毒的细胞和转录控制
- 批准号:
9160163 - 财政年份:2016
- 资助金额:
$ 2.85万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Molecular Mechanisms of TOX-mediated Programming of CD8 T Cell Exhaustion
TOX 介导的 CD8 T 细胞耗竭编程的分子机制
- 批准号:
10606385 - 财政年份:2023
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10743327 - 财政年份:2022
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10721409 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10536743 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
- 批准号:
10311054 - 财政年份:2019
- 资助金额:
$ 2.85万 - 项目类别: